Guo R, Hu J, Jing J, Liu Y, Li J, Zhou Y, Liu H, Zhou L, Chen X (2022) <br />LC-MS/MS assay of fluoropezil and its two major metabolites in human plasma: an application to pharmacokinetic studies<br /><i>Bioanalysis</i> <b>14</b>: 817<br /><br />Liu Y, Uras G, Onuwaje I, Li W, Yao H, Xu S, Li X, Phillips J, Allen S, Gong Q, Zhang H, Zhu Z, Liu J, Xu J (2022) <br />Novel inhibitors of AChE and Abeta aggregation with neuroprotective properties as lead compounds for the treatment of Alzheimer's disease<br /><i>Eur Journal of Medicinal Chemistry</i> <b>235</b>: 114305<br /><br />Qian H, Yu C, Zhu H, Ding Q, Cai Y, Jing J, Xu X, Guo R, Zhang H, Liu H, Chen X, Liu Y (2022) <br />Safety, tolerability, and pharmacokinetics of fluoropezil (DC20), a novel AChE inhibitor: a singlecenter, phase I study in healthy young and elderly Chinese subjects<br /><i>ResearchSquare</i> <br /><br />Guo R, Zhou L, Chen X (2021) <br />Desorption electrospray ionization (DESI) source coupling ion mobility mass spectrometry for imaging fluoropezil (DC20) distribution in rat brain<br /><i>Anal Bioanal Chem</i> <b>413</b>: 5835<br /><br />